Intermolecular, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2018; Provides Earnings Guidance for the First Quarter of 2019
For the year, the company reported total revenues of $33,660,000 compared with $37,203,000 for the same period a year ago. Loss from operations was $4,348,000 compared with $11,005,000 for the same period a year ago. Net loss was $3,411,000 or $0.07 per basic share compared with $10,403,000 or $0.21 per basic share for the same period a year ago.
The company provided earnings guidance for the first quarter of 2019. The company expects revenue to be in the range of $6.1 million to $6.5 million. Net loss is projected to be between $2.3 million and $3.0 million, or between $0.05 and $0.06 per share (based on approximately 49.8 million shares expected to be outstanding).